Metropolis Healthcare Limited is a leading diagnostics chain in India, with a network of over 200 labs, over 4500 collection points, and over 25000 accredited doctors. It is the largest chain of diagnostic centres in India and provides a wide range of clinical laboratory tests and services.
Metropolis is ISO 15189 and NABL accredited and is also a CAP-accredited laboratory. The company is committed to providing quality healthcare services, at affordable prices to its customers. It is continuously innovating and introducing new technologies and processes, to help improve the quality of healthcare services provided.
Metropolis Healthcare Limited has been listed on the National Stock Exchange of India since July 2018. The company’s stock price has been steadily increasing since its listing, and as of December 2022, it has a market capitalization of over Rs. 6,700 crores. The stock has been consistent in the broader markets but has seen a loss of over 61% in the last year.
METROPOLIS HEALTHCARE LIMITED IN RECENT NEWS
- Surendran Chemmenkotil to step up as the new CEO of Metropolis Healthcare Limited.
- Diagnostic firms’ share to see a rise amid the return of COVID-19 cases.
- Metropolis Healthcare announces a dividend of ₹8 per share as Q3 results show a 12% decrease in profit after tax.
HOW TO BUY METROPOLIS HEALTHCARE LIMITED SHARES IN INDIA?
To buy Metropolis Healthcare Limited shares in India, you need to open a Demat and trading account with a stockbroker. Once your account is opened, you can place an order to buy Metropolis Healthcare Limited shares.
You can place an order online through your stock broker’s online trading platform, or you can place an order through a broker over the phone. Before placing an order, it is important to research the stock and understand its past performance and current trends. Some online trading platforms are provided by Upstox, Zerodha, ICICI Direct, etc.
METROPOLIS HEALTHCARE LIMITED SHARE PRICE PREDICTION 2023-2030
For a better understanding, let us see the price targets and predictions for Metropolis Healthcare Limited’s share price over the years
METROPOLIS HEALTHCARE LIMITED SHARE PRICE TARGET 2023 IS 1847.45
| When | Maximum Price | Minimum Price |
| February 2023 | ₹1,317.00 | ₹1,059.23 |
| March 2023 | ₹1,282.75 | ₹1094.42 |
| April 2023 | ₹1,236.03 | ₹1073.87 |
| May 2023 | ₹1146.69 | ₹928.22 |
| June 2023 | ₹1,136.03 | ₹873.87 |
| July 2023 | ₹1,363.23 | ₹1,048.64 |
| August 2023 | ₹1,499.55 | ₹1,153.50 |
| September 2023 | ₹1,574.53 | ₹1,211.18 |
| October 2023 | ₹1,499.55 | ₹1,153.50 |
| November 2023 | ₹1,649.51 | ₹1,268.85 |
| December 2023 | ₹1,847.45 | ₹1,621.11 |
The Metropolis Healthcare Limited share price target for 2023 is expected to be around Rs. 1800-1850. This is based on the company’s current performance and growth prospects. The company is well-positioned to benefit from India’s growing healthcare industry and is expected to expand its presence in the coming years.
With strong financials, increasing demand for diagnostic and preventive healthcare services, and increasing investments in research and development, Metropolis Healthcare Limited is well-positioned to benefit from the growth in the Indian healthcare industry.
However, currently Metropolis posted their Q3 results and the share is on a downtrend. This makes it a perfect time to buy Metropolis Healthcare shares for long term.
METROPOLIS HEALTHCARE LIMITED SHARE PRICE PREDICTION FOR 2024 IS 2586.51 INR
| When | Maximum Price | Minimum Price |
| January 2024 | ₹1,944.68 | ₹1,495.91 |
| February 2024 | ₹2,185.04 | ₹1,820.86 |
| March 2024 | ₹2,300.04 | ₹1,869.95 |
| April 2024 | ₹2,090.95 | ₹1,608.42 |
| May 2024 | ₹1,742.45 | ₹1,340.35 |
| June 2024 | ₹2,090.95 | ₹1,608.42 |
| July 2024 | ₹1,777.30 | ₹1,377.75 |
| August 2024 | ₹1,955.03 | ₹1,551.61 |
| September 2024 | ₹2,052.79 | ₹1,579.07 |
| October 2024 | ₹2,415.04 | ₹1,857.72 |
| November 2024 | ₹2,535.79 | ₹1,950.61 |
| December 2024 | ₹2,586.51 | ₹1,989.62 |
It is difficult to predict the exact share price of Metropolis Healthcare Limited for 2024 as there are many variables such as economic conditions, industry trends, and company performance that can affect the stock price. However, based on the company’s past performance and growth prospects, it is likely that the share price will reach Rs. 2500-2600 in 2024.
METROPOLIS HEALTHCARE LIMITED SHARE PRICE TARGET FOR 2025 IS 3137.48 INR
| When | Maximum Price | Minimum Price |
| January 2025 | ₹2,638.24 | ₹2,029.42 |
| February 2025 | ₹2,777.09 | ₹2,136.23 |
| March 2025 | ₹2,915.95 | ₹2,243.04 |
| April 2025 | ₹2,603.53 | ₹2,002.71 |
| May 2025 | ₹2,366.84 | ₹1,820.65 |
| June 2025 | ₹2,603.53 | ₹2,002.71 |
| July 2025 | ₹2,479.55 | ₹1,907.35 |
| August 2025 | ₹2,582.86 | ₹1,986.82 |
| September 2025 | ₹2,712.01 | ₹2,086.16 |
| October 2025 | ₹2,874.73 | ₹2,211.33 |
| November 2025 | ₹3,075.96 | ₹2,366.12 |
| December 2025 | ₹3,137.48 | ₹2,413.44 |
The Metropolis Healthcare Limited share price target for 2025 is expected to be around Rs. 3100-3200. This is based on the company’s current performance and growth prospects. The company is well-positioned to benefit from India’s growing healthcare industry and is expected to expand its presence in the coming years.
METROPOLIS HEALTHCARE LIMITED SHARE PRICE TARGET 2026-2030
| Year | Maximum Price | Minimum Price |
| 2026 | ₹2,196.23 | ₹1,537.36 |
| 2027 | ₹1,866.80 | ₹1,306.76 |
| 2028 | ₹3,360.24 | ₹2,352.17 |
| 2029 | ₹6,902.45 | ₹4,831.71 |
| 2030 | ₹7,686.82 | ₹5,380.77 |
After 2025, the stock price will fall from 3000 INR to 2000 INR in 2026 and later to 1000 INR in 2027. This will then see a spike and will reach to the mark of 3360 INR in 2028 and will double itself in 2029 and reach around 6500-6900 INR and would again see relatively steady growth in 2030. At the end of 2030, it is predicted to reach the price of ₹7686.82.
METROPOLIS HEALTHCARE LIMITED FINANCIAL CONDITION: LAST 5 YEARS
| Narration | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Trailing | Best Case | Worst Case |
| Sales | 647.16 | 761.18 | 856.41 | 997.99 | 1,228.34 | 1,179.16 | 1,511.86 | 1,407.87 |
| Expenses | 466.59 | 558.61 | 619.20 | 708.20 | 880.26 | 881.46 | 1,082.70 | 1,052.43 |
| Operating Profit | 180.57 | 202.57 | 237.21 | 289.79 | 348.08 | 297.70 | 429.16 | 355.44 |
| Other Income | 5.67 | 8.17 | -16.56 | 12.04 | 33.51 | 15.67 | – | – |
| Depreciation | 19.02 | 20.07 | 39.27 | 45.94 | 63.22 | 77.62 | 77.62 | 77.62 |
| Interest | 3.54 | 4.12 | 12.65 | 11.56 | 25.02 | 25.55 | 25.55 | 25.55 |
| Profit before tax | 163.68 | 186.55 | 168.73 | 244.33 | 293.35 | 210.20 | 325.99 | 252.27 |
| Tax | 51.84 | 62.94 | 41.18 | 60.97 | 78.66 | 54.77 | 26% | 26% |
| Net profit | 104.24 | 120.15 | 127.33 | 183.10 | 214.18 | 154.76 | 241.05 | 186.54 |
| EPS | 109.73 | 23.93 | 25.16 | 35.83 | 41.83 | 30.22 | 47.07 | 36.43 |
| Price to earning | 51.04 | 62.55 | 48.66 | 43.87 | 51.53 | 43.87 | ||
| Price | – | – | 1,284.45 | 2,241.20 | 2,035.75 | 1,326.00 | 2,425.86 | 1,598.29 |
| RATIOS: | ||||||||
| Dividend Payout | 0.00% | 55.41% | 31.82% | 22.33% | 19.11% | |||
| OPM | 27.90% | 26.61% | 27.70% | 29.04% | 28.34% | 25.25% |
Metropolis Healthcare’s Q3 FY23 Results
Metropolis Healthcare’s Q3 FY23 Results Show a Decrease in Net Profit and Revenue – YoY Comparison. The company reported a net profit of ₹35.80 crore, down 12.77% from ₹41.04 crore in the same period the previous year. The company’s revenue from operations was ₹285.46 crore, a 2.60% decrease from ₹293.05 crore in the same quarter of the previous year.
The company’s expenses increased to ₹244.10 crore in Q3FY23 compared to ₹239.57 crore in the same quarter of the previous year. The EPS was ₹6.99 in Q3FY23, down from ₹8.02 in the same quarter of the previous year.
Metropolis Healthcare Recent Dividend Announcement
Metropolis Healthcare has announced an interim dividend of ₹8 per share for the financial year 2022-23. The record date for determining eligibility for the dividend is February 23, 2023, and it will be paid to shareholders within 30 days of the declaration.
Metropolis Share Price Prediction by Experts
Metropolis Share Price Target by ICICI Securities
ICICI Securities recommends buying Metropolis Healthcare with a target price of Rs 1926.
Metropolis Share Price Target by BNP Paribas
BNP Paribas, a brokerage firm, has a “Buy” rating on Metropolis Healthcare, an Indian pharmaceutical stock, with a target price of ₹2,052 per share.
Metropolis Share Price Target by Yes Securities
YES Securities recommends buying Metropolis Healthcare, with a target of Rs. 1720.
FAQs
Will Metropolis Healthcare Limited’s stock price grow in 2023?
It’s hard to say if Metropolis Healthcare Limited’s stock price will increase in 2023 since there are a lot of factors like economic conditions, industry trends, and company performance that can influence the stock price. Nevertheless, based on the company’s prior performance and potential for growth, it seems the stock price will continue to rise in the upcoming years.
What is the Market Cap of Metropolis Healthcare Limited?
Metropolis Healthcare Limited has a market capitalization of over Rs. 6,700 crores as of December 2022.
What do you anticipate the share price of Metropolis Healthcare Limited to be in the year 2024?
The share price of Metropolis Healthcare Limited is expected to reach Rs. 2500-2600 in 2024, based on the company’s current performance and growth prospects.
Can Metropolis Healthcare Limited reach 3000 INR?
At this time, it is difficult to predict whether Metropolis Healthcare Limited will reach 3000 INR in the future. However, based on the company’s past performance and growth prospects, it is likely that the stock price will continue to grow in the coming years.
What is Metropolis Healthcare Share Price Prediction 2025?
2025 is expected to be a bullish year for Metropolis. Metropolis healthcare share price prediction for 2025 suggests, it could be trading between ₹1,820.65 to ₹3137
What is Metropolis Healthcare Share Price Target 2030?
Metropolis healthcare share price prediction for 2030 suggests, it could be trading between ₹7,686.82(maximum) to ₹5,380.77.
CONCLUSION: Should you buy Metropolis Healthcare in 2023?
Metropolis Healthcare Limited is a leading diagnostics chain in India, with a network of over 200 labs and over 25000 accredited doctors. The company is committed to providing quality healthcare services, at affordable prices to its customers. Metropolis Healthcare Limited has been listed on the National Stock Exchange of India since July 2018 and has a market capitalization of over Rs. 13,000 crores as of May 2021.
The share price of Metropolis Healthcare Limited is expected to reach Rs. 3,137.48 in 2025, based on the company’s current performance and growth prospects.
The company may announce bonus shares in the future, depending on the performance of the company.
One should have Metropolis Healthcare is his portfolio. This could be one of the multibagger stocks for future.
Another company in the hospital industry you may want to look into is Rainbow hospitals.
Linkedin
